TNF and rheumatoid arthritis: Conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs), such as methotrexate (MTX), and biological DMARDs, including tumor necrosis factor (TNF) inhibitors, interleukin (IL)-6 receptor antibodies, and abatacept, have become widely used for RA.